Testing of a Navigation Intervention for Hepatitis C and HIV (LINKHCV)
Adaptation and Testing of a Navigation Intervention for Hepatitis C and HIV Co-infected Persons Leaving LA County Jail
Sponsor: University of California, Los Angeles
Terminated
Insufficient enrollment numbers due to Covid-19 pandemic
Other terminated trials from University of California, Los Angeles
- Crohn Disease · Phase NA · Mar 2025
- Insomnia · Phase NA · Feb 2024
- Health Care Utilization · Phase NA · Oct 2023
- Cessation, Tobacco · Phase PHASE2 · Jul 2023
- Glaucoma · Phase PHASE4 · Dec 2022
See all terminations from University of California, Los Angeles
Listed as NCT04499651, this NA trial focuses on HIV (Human Immunodeficiency Virus) and Hepatitis C and remains terminated or withdrawn. Sponsored by University of California, Los Angeles, it has been updated 5 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Mar 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jul 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .